Emulate
Human biology on a chip.
- Headquarters
- Boston, Massachusetts
- Employees
- 51–200
- Founded
- 2013
- Business Model
- B2B
- Website
- emulatebio.com
- Total Funding
- $203.0M
- Last Round
- $82.0M Series ESep 2021
About
Emulate, Inc. is the pioneer of Organ-on-a-Chip technology, spun out of Harvard's Wyss Institute in 2013. The company commercializes its Human Emulation System — microfluidic chips lined with living human cells that replicate organ-level biology — enabling pharmaceutical and biotech researchers to model disease and test drug candidates.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account